Barcelona snapshots

Dr. Diego Hidalgo-Mazzei

Diego Hidalgo-Mazzei psiquiatra Controversies Psiquiatria Barcelona
IDIBAPS, Hospital Clínic de Barcelona
Ponència Marcadors digitals i intel·ligència artificial: la solució definitiva
Data Divendres, 21 d'abril, 2023
Hora 12:00 - 12:45
Taula rodona 2 Diagnòstic de precisió en psiquiatria: aconseguirem canviar de model?


Diego Hidalgo-Mazzei (MD, PhD) is a psychiatrist and postdoctoral researcher at the Barcelona Bipolar and Depressive Disorders Unit, Department of Psychiatry and Psychology at the Hospital Clínic of Barcelona. Over the last 10 years, his main area of research has been the use of new technologies in affective disorders, having participated in several national and international projects developing and evaluating digital tools. As a result, Dr Hidalgo-Mazzei has collaborated on and published several scientific papers (68) in this area. His current H-index is 24. His thesis dissertation (2016) was also written on the same subject and was awarded a cum laude mention, an extraordinary doctoral award by the University of Barcelona, as well as a prize for the 2016 best doctoral dissertation by the Spanish Association of Biological Psychiatrists. His work has received numerous national and international awards. Dr. Hidalgo-Mazzei has been the Principal Investigator of several national and international projects using digital technologies in affective disorders. He has worked as a postdoctoral researcher at the Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK, where he is currently a visiting researcher. He is an active member of the Big data task force at the International Society for Bipolar Disorders (ISBD) and the Digital network of the European College of Neuropsychopharmacology (ECNP).


The constant growth and widespread availability of digital mobile technologies (i.e. smartphones and wearables) and advancements in artificial intelligence (AI) over the last decades have been a subject of intense interest and research in psychiatry. The potential of these digital tools at collecting a new kind of passive and active information (known as digital markers) to determine illness activity and also provide cost-effective and tailored interventions based on them, have raised many hopes. In this session, we will briefly review the latest evidence-based advancements in the field of psychiatry using mobile digital technologies and AI, particularly in mood disorders. Challenges in the academic field hampering the advancement of these technologies and its implementation into clinical practice will be discussed.


[Full paper] Anmella G, ..., Vergari A, Hidalgo-Mazzei D. (2023). Exploring digital biomarkers of illness activity in mood episodes: hypotheses generating and model development study. JMIR Mhealth Uhealth. 2023 Mar 7. doi: 10.2196/45405. Epub ahead of print. PMID: 36939345.

[Full paper] Anmella G, ..., Hidalgo-Mazzei D. (2023). Vickybot, a Chatbot for Anxiety-Depressive Symptoms and Work-Related Burnout in Primary Care and Health Care Professionals: Development, Feasibility, and Potential Effectiveness Studies". J Med Internet Res. 2023 Apr 3;25:e43293. doi: 10.2196/43293. PMID: 36719325.

[Full paper] Hidalgo-Mazzei D, Young AH, Vieta E, Colom F. Behavioural biomarkers and mobile mental health: a new paradigm. Int J Bipolar Disord. 2018 May 6;6(1):9. doi: 10.1186/s40345-018-0119-7. PMID: 29730832; PMCID: PMC6161977.